欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Mus dunni Proteasome subunit beta type-9 (Psmb9) CSB-YP018887MUV
CSB-EP018887MUV
CSB-BP018887MUV
CSB-MP018887MUV
CSB-EP018887MUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Cyclin-dependent kinase 17 (Cdk17) CSB-YP017649RA
CSB-EP017649RA
CSB-BP017649RA
CSB-MP017649RA
CSB-EP017649RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cricetulus griseus Calcipressin-1 (RCAN1) CSB-YP019500DXU
CSB-EP019500DXU
CSB-BP019500DXU
CSB-MP019500DXU
CSB-EP019500DXU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryzias latipes Hepatocyte nuclear factor 3-beta (foxa2) CSB-YP008795OFH
CSB-EP008795OFH
CSB-BP008795OFH
CSB-MP008795OFH
CSB-EP008795OFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Fibulin-1 (fbln1), partial CSB-YP008452DIL
CSB-EP008452DIL
CSB-BP008452DIL
CSB-MP008452DIL
CSB-EP008452DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meleagris gallopavo Growth/differentiation factor 8 (MSTN) CSB-YP015057MQV
CSB-EP015057MQV
CSB-BP015057MQV
CSB-MP015057MQV
CSB-EP015057MQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Guanine nucleotide-binding protein subunit beta-2-like 1 (gnb2l1) CSB-YP009605DIL
CSB-EP009605DIL
CSB-BP009605DIL
CSB-MP009605DIL
CSB-EP009605DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Carassius auratus Flotillin-2 (flot2) CSB-YP008728DQG
CSB-EP008728DQG
CSB-BP008728DQG
CSB-MP008728DQG
CSB-EP008728DQG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio E3 ubiquitin-protein ligase Mdm2 (mdm2) CSB-YP013626DIL
CSB-EP013626DIL
CSB-BP013626DIL
CSB-MP013626DIL
CSB-EP013626DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Beta-1 adrenergic receptor (adrb1), partial CSB-YP001391XBE1
CSB-EP001391XBE1
CSB-BP001391XBE1
CSB-MP001391XBE1
CSB-EP001391XBE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Corticotropin-releasing factor receptor 2 (crhr2), partial CSB-YP005966XBE
CSB-EP005966XBE
CSB-BP005966XBE
CSB-MP005966XBE
CSB-EP005966XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Serine/threonine-protein kinase rio1 (rio1) CSB-YP019732SXV
CSB-EP019732SXV
CSB-BP019732SXV
CSB-MP019732SXV
CSB-EP019732SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Pterin-4-alpha-carbinolamine dehydratase (omt2) CSB-YP017514SXV
CSB-EP017514SXV
CSB-BP017514SXV
CSB-MP017514SXV
CSB-EP017514SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Tetratricopeptide repeat protein 1 (tpr1), partial CSB-YP025203SXV
CSB-EP025203SXV
CSB-BP025203SXV
CSB-MP025203SXV
CSB-EP025203SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Anaphase-promoting complex subunit 4 (cut20), partial CSB-YP001699SXV
CSB-EP001699SXV
CSB-BP001699SXV
CSB-MP001699SXV
CSB-EP001699SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe RNA polymerase II subunit A C-terminal domain phosphatase ssu72 (ssu72) CSB-YP022729SXV
CSB-EP022729SXV
CSB-BP022729SXV
CSB-MP022729SXV
CSB-EP022729SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Exosome complex component rrp46 (rrp46) CSB-YP007893SXV
CSB-EP007893SXV
CSB-BP007893SXV
CSB-MP007893SXV
CSB-EP007893SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Anaphase-promoting complex subunit 10 (apc10) CSB-YP001695SXV
CSB-EP001695SXV
CSB-BP001695SXV
CSB-MP001695SXV
CSB-EP001695SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe U6 snRNA-associated Sm-like protein LSm5 (lsm5) CSB-YP013208SXV
CSB-EP013208SXV
CSB-BP013208SXV
CSB-MP013208SXV
CSB-EP013208SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe DNA-directed RNA polymerase I subunit rpa43 (rpa43) CSB-YP025360SXV
CSB-EP025360SXV
CSB-BP025360SXV
CSB-MP025360SXV
CSB-EP025360SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×